Amid public concern over spiking drug prices, a powerful middleman is suing a tiny drugmaker over unpaid rebates and fees. The maker calls the suit baseless; analysts say the suit offers a window into an opaque world.
by Charles Ornstein, ProPublica | Jun 4, 2017
The dean of Yale’s medical school, the incoming president of a prominent cancer group and the head of a Texas cancer center are among leading medical figures who have not accurately disclosed their relationships with drug companies.
by Charles Ornstein, ProPublica | Dec 10, 2018
The executive order separates families who made every effort to follow U.S. immigration law.
by Charles Ornstein, ProPublica | Jun 26, 2018
Faced with competition, some pharmaceutical companies are cutting deals with insurance companies to favor their brand-name products over cheaper generics. Insurers pay less, but sometimes consumers pay more.
by Charles Ornstein, ProPublica | Aug 7, 2017
Some Medicare beneficiaries are being prescribed opioids by 10 or more doctors, or are filling prescriptions for more than 1,000 pills a month. Hundreds of doctors appear to be prescribing indiscriminately.
by Charles Ornstein, ProPublica | Jul 16, 2017
Some say it violates the First Amendment. Legislators say it’s about promoting a “healthy, civil dialogue.” Expect court battles ahead.
by Charles Ornstein, ProPublica | Jun 10, 2017
© 2019 Boise Weekly